Nutra Pharma sales and marketing update

Nutra's drug discovery subsidiary, ReceptoPharm Inc., will provide its RPI-78M under a compassionate use program to patients who were enrolled in a completed Phase IIb/IIIa trial to treat adrenomyelo...